Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Agnosia × Nerve Block × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Skin Cancer Face 1 Pain, Postoperative 1 Pain 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Chronic Pain 1 Agnosia 1

Interventions

Bupivacaine 9 Ketamine 8 Dexmedetomidine 7 Ropivacaine 6 Fentanyl 6 Anesthesia, General 6 Analgesics, Opioid 6 Acetaminophen 6 Morphine 5 Lidocaine 5 Acupuncture Therapy 5 Tramadol 4 Sodium Chloride 4 Pregabalin 4 Ethanol 4 Anesthesia, Local 4 parecoxib 3 Saline Solution 3 Radiofrequency Ablation 3 Propofol 3 Ketorolac 3 Control Groups 3 Anesthetics, Local 3 Analgesia, Epidural 3 trimebutine 3-thiocarbamoylbenzenesulfonate 2 Transcutaneous Electric Nerve Stimulation 2 Surveys and Questionnaires 2 Oxycodone 2 Magnesium Sulfate 2 Levobupivacaine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01089933 2025-04-04

RELIeF

Ottawa Hospital Research Institute

Phase NA Completed

129 enrolled 6 charts

Agnosia, Breast Neoplasms, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡